217 related articles for article (PubMed ID: 14509206)
1. Quetiapine treatment in a patient with Tourette's syndrome, obsessive-compulsive disorder and drug-induced mania.
Matur Z; Uçok A
Isr J Psychiatry Relat Sci; 2003; 40(2):150-2. PubMed ID: 14509206
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
Diniz JB; Shavitt RG; Fossaluza V; Koran L; Pereira CA; Miguel EC
J Clin Psychopharmacol; 2011 Dec; 31(6):763-8. PubMed ID: 22020357
[TBL] [Abstract][Full Text] [Related]
3. Tourette's syndrome and treatment with clomipramine hydrochloride.
Donahoe DH; Meador M; Fortune T; Llorena R
W V Med J; 1991 Oct; 87(10):468-70. PubMed ID: 1767522
[TBL] [Abstract][Full Text] [Related]
4. Quetiapine in treatment-resistant obsessive-compulsive disorder.
Cohen LS
J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):623-4. PubMed ID: 12921466
[No Abstract] [Full Text] [Related]
5. Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial.
Diniz JB; Shavitt RG; Pereira CA; Hounie AG; Pimentel I; Koran LM; Dainesi SM; Miguel EC
J Psychopharmacol; 2010 Mar; 24(3):297-307. PubMed ID: 19164490
[TBL] [Abstract][Full Text] [Related]
6. Low-Dose Quetiapine Fumarate (50 mg) for Obsessive-Compulsive Disorder Patients With Comorbid Bipolar Depression.
Poyurovsky M; Weizman A
Clin Neuropharmacol; 2021 Sep-Oct 01; 44(5):196-197. PubMed ID: 34456228
[No Abstract] [Full Text] [Related]
7. Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder.
Mohr N; Vythilingum B; Emsley RA; Stein DJ
Int Clin Psychopharmacol; 2002 Jan; 17(1):37-40. PubMed ID: 11800505
[TBL] [Abstract][Full Text] [Related]
8. Quetiapine addition in obsessive-compulsive disorder: is treatment outcome affected by type and dose of serotonin reuptake inhibitors?
Denys D; Fineberg N; Carey PD; Stein DJ
Biol Psychiatry; 2007 Feb; 61(3):412-4. PubMed ID: 17241831
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine in patients with Tourette's disorder: an open-label, flexible-dose study.
de Jonge JL; Cath DC; van Balkom AJ
J Clin Psychiatry; 2007 Jul; 68(7):1148-50. PubMed ID: 17685760
[No Abstract] [Full Text] [Related]
10. Quetiapine augmentation of sertraline in obsessive-compulsive disorder.
Francobandiera G
J Clin Psychiatry; 2002 Nov; 63(11):1046-7. PubMed ID: 12469688
[No Abstract] [Full Text] [Related]
11. Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: a meta-analysis of randomized controlled treatment trials.
Fineberg NA; Stein DJ; Premkumar P; Carey P; Sivakumaran T; Vythilingum B; Seedat S; Westenberg H; Denys D
Int Clin Psychopharmacol; 2006 Nov; 21(6):337-43. PubMed ID: 17012980
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.
Denys D; de Geus F; van Megen HJ; Westenberg HG
J Clin Psychiatry; 2004 Aug; 65(8):1040-8. PubMed ID: 15323587
[TBL] [Abstract][Full Text] [Related]
13. Clozapine-induced obsessive-compulsive symptoms in bipolar disorder.
Lemke NT; Bustillo JR
Am J Psychiatry; 2013 Aug; 170(8):930. PubMed ID: 23903341
[No Abstract] [Full Text] [Related]
14. Quetiapine for Bipolar Depressive Episode in Obsessive-Compulsive Disorder Patients Maintained on Selective Serotonin Reuptake Inhibitor Treatment.
Poyurovsky M; Weizman A
Clin Neuropharmacol; 2021 Jul-Aug 01; 44(4):123-125. PubMed ID: 33811191
[TBL] [Abstract][Full Text] [Related]
15. Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study.
Kordon A; Wahl K; Koch N; Zurowski B; Anlauf M; Vielhaber K; Kahl KG; Broocks A; Voderholzer U; Hohagen F
J Clin Psychopharmacol; 2008 Oct; 28(5):550-4. PubMed ID: 18794652
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: an open-label study.
Bogan AM; Koran LM; Chuong HW; Vapnik T; Bystritsky A
J Clin Psychiatry; 2005 Jan; 66(1):73-9. PubMed ID: 15669891
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.
Denys D; van Megen H; Westenberg H
J Clin Psychiatry; 2002 Aug; 63(8):700-3. PubMed ID: 12197450
[TBL] [Abstract][Full Text] [Related]
18. Risperidone treatment for a Tourette's disorder patient with comorbid obsessive-compulsive disorder.
Giakas WJ
Am J Psychiatry; 1995 Jul; 152(7):1097-8. PubMed ID: 7540801
[No Abstract] [Full Text] [Related]
19. Effects of quetiapine on cognitive functioning in obsessive-compulsive disorder.
de Geus F; Denys D; Westenberg HG
Int Clin Psychopharmacol; 2007 Mar; 22(2):77-84. PubMed ID: 17293707
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine augmentation of selective serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a six-month follow-up case series.
Dell'Osso B; Mundo E; Altamura AC
CNS Spectr; 2006 Nov; 11(11):879-83; quiz 885. PubMed ID: 17075559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
